This is an Open Access article licensed under the terms of the Creative Commons AttributionNonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only. how it interacts with TIGAR. Methods: We performed real-time PCR, western blotting, CCK8, 144 to lung cancer cells. Results: miR-144 targeted TIGAR, inhibited proliferation, enhanced Conclusions: Our study improves our understanding of the mechanisms underlying lung cancer pathogenesis and may promote the development of novel targeted therapies.
MiR-144 Inhibits Proliferation and Induces Apoptosis and Autophagy in Lung Cancer

Introduction
MiRNAs are noncoding RNAs of 20-24 nucleotides that function as post-transcriptional negative regulators of gene expression [1] . It is now well known that miRNAs regulate the in cancer development and progression [2, 3] . MiR-144, sharing the same locus with miR-451 [4] , has been reported in many cancers. A report from Zhang et al. claimed that miR-144 promoted proliferation, migration, and invasion of nasopharyngeal carcinoma through repression of phosphatase and tensin homolog (PTEN) [5] . Sureban et al. also showed that knockdown of doublecortin and CaM kinase-like-1 (DCAMKL-1) increased miR-144 expression, which in turn inhibited epithelial-mesenchymal transition (EMT) of pancreatic cancer [6] . These data impelled us to further study the relative mechanism of miR-144 acting on lung cancer behavior.
Lung cancer is a major cause of cancer-related death worldwide. Although the diagnosis and therapy are in advances and the prognosis is encouraging, the number of cases and deaths related to lung cancer is still rising in many parts of the world. Lung cancer consisted of multiple sequential steps that are not completely understood to date, more investigation of this mechanism is urgently needed. Altered expression of miRNAs has been observed in lung cancer, suggesting that miRNA deregulation plays a role in lung carcinogenesis. For example, miR-145 inhibited lung cancer cell metastasis and EMT via targeting the Oct4 as a potential therapeutic approach to overcome radioresistance for lung cancer treatment X-chromosomal protein (ZFX) expression, which seems to be associated with tumorigenesis [8] . Our previously studies also found that the expression of miR-144 in these tissues was lower than in adjacent, paired non-tumor tissues by a miRNA chip-based expression analysis of lung cancer tissues.
Relevant bioinfomatics were analyzed and we hypothesized that miR-144 interacted with the p53-induced glycolysis and apoptosis regulator (TIGAR). TIGAR was discovered through microarray analysis of gene expression following the activation of p53 [9] . It is a p53-induced gene that can reduce the level of fructose2, 6-bisphosphate in cells, resulting in inhibition of glycolysis, and plays a crucial role in apoptosis [10, 11] . TIGAR overexpression has been described in several types of tumor. Its expression is increased in primary colon cancer and associated metastases [12] , as well as in invasive breast cancer when compared to normal tissue [13] . TIGAR is also overexpressed in glioblastoma [14] . The effect of miR-144 on lung cancer cells and how it interacts with TIGAR remain unknown. In the present study, we observed miR-144 expression levels in tissues from 67 lung cancer patients, and investigated the function of miR-144 in lung cancer cells.
Materials and Methods
Patients and tissue specimens
A total of 67 cases of lung cancer cases were examined. All specimens were clinically and histologically and written consent was obtained from all patients.
RNA extraction
For lung cancer tissues, if the proportion of lung cancer cells in a tissue section was >80% then the frozen block was subjected to RNA extraction. According to the manufacturer's protocol, total RNA was extracted from 67 pairs of snap-frozen cancer tissues and adjacent normal tissues using TRIzol reagent value of OD 260 /OD 280 is around 1.8 as a criterion of acceptable purity. control. All samples were analyzed three times. The qRT-PCR results were expressed relative to miR-144 expression levels at the threshold cycle (Ct), which were then converted to fold changes (2 ).
Cell lines and reagents
streptomycin, and the cells were incubated at 37°Cunder 5% CO 2 atmosphere.
The miR-144 agomir (GMR-miRmicroRNA-144 agomir) and miR-144 scramble were synthesized 2×10 7 and the miR-144 agomir transfected group (miR-144).
The total protein content of cultured cells was extracted using RIPA buffer containing 4°Covernight. To detect autophagy, the markers of autophagic vacuoles, microtubule-associated protein 1 -peroxidase -conjugated goat endogenous reference.
CO 2 consecutive days at 490 nm (OD 490 ) to estimate viable cell numbers. The assay was repeated in three independent experiments.
Cells were trypsinized, counted and propagated after transfection, and then cultured in six-well plates at 100 cells/well. The number of colonies was counted at 12daysafter seeding. The colonies formed were stained with crystal violet, and the colonies with >50 cells were scored as surviving colonies. This experiment had three replicates.
Tumor heterotransplantation was performed to investigate tumorigenic ability of miR-144 . A549 cells transfected with miR-144(miR-144 group) or with scrambled miRNA (scramble group) and handling and experimental procedures were approved by the Animal Experimental Ethics Committee of month. The mice were killed and tumors were removed, photographed and weighed. Tumor volumes were Cell cycle was synchronized for 24 h before collection and 20,000 cells were detected per group. The cells were suspended in 500 μl binding buffer and 10 μl AnnexinVpropidium iodidewere added for 15 min. All the procedures were done according to the instructions of the carried out in triplicate.
Cells from each treatment group were harvested at 48 h post-transfection and caspase activity was added to each well of the plates, followed by 1 min mixing using an IKA MTS4 plate shaker. Plates were incubated at room temperature for 2 h. Absorbance values were measured with a microplate reader at 405 on a computer with a digital camera attached to the microscope, and the images were merged by computer.
Each group of cells was plated on 24-well plates after transfection for 24 h. Exponentially growing cells were treated with 0.05 mM MDC (Sigma) in DMEM at 37°C for 10 min. After that, the cells were washed three an excitation wavelength of 380 nm and emission wavelength of 450 nm. miR-144 data of 67 pairs of primary tumors and normal lung tissues were downloaded from The Cancer Genome Atlas (TCGA) website () [15] , and analyzed using Multi-Experiment Viewer (MeV) software (version 4.9, ). The fold differences in miRNA expression were compared by paired . do) [16, 17] . The
The human TIGAR 3
For the luciferase reporter assay, A539 cells were co-transfected with miRNA (miR-144 agomir or scrambled-miR-144 negative control) and reporter vectors (pmirGLO-WT reporter vectors or pmirGLOpost-transfection. Experiments were repeated three times in triplicate.
All data are expressed as means ± standard deviation. Statistical testing was analyzed using SPSS version 17.0 statistical software. The t-test and one-way analysis of variance were used to analyze data. P<
Results
To calculate relative miR-144 concentrations by fold changes (2 -Ct lower in lung cancer tissues than in paired adjacent normal tissues (*P < 0.05). The clinicopathological characteristics of the 67 lung cancer cases are presented in Table  1 . Of the 67 lung cancer patients, miR-144 expression was related to tumor size (< 0.41±0.124 vs. > P < 0.01 , Table 1 ). And miR-144 expression level TNM (*P < 0.01, Table 1 ). MiR-144 expression was also lower in the lymph node metastasispositive group than the negative group (0.31±0.069 vs. 0.42±0.116, respectively, *P differences were detected with CLPTM1L mRNA expression (P > 0.05, Table 1 , Fig. 1F , between miR-144 expression and gender, age, smoking, differentiation or histology (P > 0.05, Table 1 ). values between the blank and scramble groups (P > 0.05). Compared with the blank and scramble groups, the OD 490 (*P P < 0.05, Fig.  1E, 1F) . The result remains coordinate in tumor heterotransplantation experiment that the tumor volumes of miR-144 group cells were relatively lower than scramble group and blank group (*P Flow cytometry indicated that the apoptosis rate in the miR-144 group was higher than P Caspase3/7 activity in miR-144 group was higher than in the scramble and blank groups was increased compared to the other groups (*P approximately 2 weeks of incubation, the colony formation number of miR-144 group cells came to lower P --red every week. The tumor volumes of miR group cell were relatively lower than scramble group and blank group (*P < 0.05).
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Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry blank group, but lower than in the miR-144 group (*P intensity of the si-TIGAR group was higher than in the blank and miR-144 groups (*P < 0.05, Fig. 5E ). While these results indicate that the functions of TIGAR and miR-144 in A549 cells are largely similar, their degree of function to A549 cell is somewhat inconsistent which supports that the function of miR-144 in A549 cells is partially attributed to targeting TIGAR.
Discussion
MiRNAs are a class of small noncoding single-stranded RNA molecules that are found in plants, animals, and some viruses, which function in RNA silencing and post-transcriptional 
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Cellular Physiology and Biochemistry regulation of gene expression [18, 19] . Most miRNAs exist as single copies, multiple copies or clusters in the genome, and most of them have a hairpin structure. miRNAs function via base pairing with complementary sequences within mRNA molecules [20] [21] [22] [23] , cutting off the mRNA molecule on target genes, or inhibiting translation of target genes. Some research has human lung cancer. We found that altered miR-144 expression levels were associated with and autophagy were enhanced after transfection with miR-144 mimics. These results imply that miR-144 acts as an inhibitor of lung cancer, and that it contributes to the development, progression and metastasis of lung cancer. Autophagy is a catabolic process that is correlated with various physiological procedures and pathological conditions including cancer. It refers to the degradation of unnecessary cells or dysfunctional organelles using lysosomes [32] [33] [34] [35] . In the autophagic process, LC3 I, a soluble form in the cytoplasm, transforms into LC3 II which localizes on the autophagosome membrane [36] . Another protein with a known role in mediating autophagy P < 0.05). This may imply that miR-144 can and development of lung cancer.
144 was TIGAR (NM_020375), which lay within a cancer susceptibility locus on chromosome 12. TIGAR was discovered by microarray analysis of gene expression following activation of p53.TIGAR overexpression is observed in several types of tumor. Functions of TIGAR primarily manifest in lowering glycolysis, which results in the elimination of reactive oxygen species. All of these functions lead to less cell death, protection from apoptosis, and inhibition of autophagy. TIGAR affects the development of different types of tumors. For instance, in nasopharyngeal cancer cells, inhibition ofc-Met, a tyrosine kinase whose overexpression is associated with poor survival and metastasis [38] , results in lower expression of TIGAR and increased cell death [39] . Also, knockdown of TIGAR by RNA interference induces apoptosis into the pmirGLO vector to construct a luciferase reporter plasmid, and qRT-PCR, western blotting, luciferase reporter and knockdown assays were performed. The CCK-8 assay, colony demonstrated that silencing TIGAR had similar functional effects as enhanced expression of miR-144. These results indicated that miR-144 might act as a metastasis suppressor by targeting TIGAR.
In conclusion, we showed that miR-144 expression is lower in human lung cancer. We propose that miR-144 might be used as a therapeutic agent against lung cancer. 
